SCYNEXIS Statistics
NASDAQ: SCYXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.25-0.53 (-11.09%)
Market open · Delayed 15 min · as of Oct 8, 2:20 PM ET
SCYNEXIS by the numbers
SCYNEXIS has a market capitalization of $42.3 million based on 9.95M shares outstanding. With trailing EPS of $-0.89, SCYNEXIS is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.7% below its 50-day average and 24.7% below its 200-day average.
Average daily trading volume is 274.80K shares, or about $1.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SCYX valuation vs. peer median
| Metric | SCYX | Peer median | Difference |
|---|---|---|---|
| Market cap | $42.29M | $49.44M | -14% |
| Avg. volume | 274.80K | 346.45K | -21% |
Peer median across 8 companies: ELTX, CRVO, CELU, ANVS, EDSA, DWTX, HYPD, SER.
Valuation
- Market cap
- $42.29M
- EPS (TTM)
- $-0.89
- Shares outstanding
- 9.95M
Price and trading
- Previous close
- 4.78
- Open
- 4.70
- Day range
- 4.25 – 4.75
- 52-week range
- 3.53 – 9.12
- 52-week change
- -24.65%
- Beta
- —
- Volume
- 200.61K
- Average volume
- 274.80K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 42.29M
- Forward Pe
- -1.84
- Eps
- -0.89
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.12
- Week52 Low
- 3.53
- Avg Volume
- 274.80K
- Shares Outstanding
- 9.95M
- Ma50
- 4.92
- Ma200
- 5.64
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -53.40%
- Pct From52w Low
- 20.40%